D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,105
- Value
- $1.54M
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,105 | $1.54M | <0.1% | −245,855−98.8% | Reduced | Holders |
| Q1 2026 | 248,960 | $111.2M | 0.1% | +248,960 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −3,343−100.0% | Sold out | Holders |
| Q3 2025 | 3,343 | $1.31M | <0.1% | −16,738−83.4% | Reduced | Holders |
| Q2 2025 | 20,081 | $8.94M | <0.1% | −51,852−72.1% | Reduced | Holders |
| Q1 2025 | 71,933 | $34.9M | <0.1% | −193,751−72.9% | Reduced | Holders |
| Q4 2024 | 265,684 | $107.0M | 0.1% | +127,276+92.0% | Added | Holders |
| Q3 2024 | 138,408 | $64.4M | 0.1% | −31,655−18.6% | Reduced | Holders |
| Q2 2024 | 170,063 | $79.7M | 0.1% | −185,395−52.2% | Reduced | Holders |
| Q1 2024 | 355,458 | $148.6M | 0.2% | +142,477+66.9% | Added | Holders |
| Q4 2023 | 212,981 | $86.7M | 0.1% | −44,012−17.1% | Reduced | Holders |
| Q3 2023 | 256,993 | $89.4M | 0.1% | +5,235+2.1% | Added | Holders |
| Q2 2023 | 251,758 | $88.6M | 0.1% | +46,826+22.8% | Added | Holders |
| Q1 2023 | 204,932 | $64.6M | 0.1% | +94,399+85.4% | Added | Holders |
| Q4 2022 | 110,533 | $31.9M | 0.1% | −7,720−6.5% | Reduced | Holders |
| Q3 2022 | 118,253 | $34.2M | 0.1% | −160,491−57.6% | Reduced | Holders |
| Q2 2022 | 278,744 | $78.5M | 0.1% | −465,504−62.5% | Reduced | Holders |
| Q1 2022 | 744,248 | $194.2M | 0.3% | −277,075−27.1% | Reduced | Holders |
| Q4 2021 | 1,021,323 | $224.3M | 0.3% | −693,311−40.4% | Reduced | Holders |
| Q3 2021 | 1,714,634 | $311.0M | 0.4% | +937,619+120.7% | Added | Holders |
| Q2 2021 | 777,015 | $156.7M | 0.2% | +230,391+42.1% | Added | Holders |
| Q1 2021 | 546,624 | $117.5M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.